Strata Critical Medical (SRTA) Stock Overview
Provides time-critical logistics and medical services to the healthcare industry in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
SRTA Community Fair Values
Create NarrativeSee what 25 others think this stock is worth. Follow their fair value or set your own to get alerts.
Strata Critical Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.04 |
| 52 Week High | US$6.02 |
| 52 Week Low | US$2.51 |
| Beta | 2.11 |
| 1 Month Change | -14.41% |
| 3 Month Change | -28.87% |
| 1 Year Change | 50.19% |
| 3 Year Change | 49.63% |
| 5 Year Change | -59.48% |
| Change since IPO | -58.56% |
Recent News & Updates
Recent updates
Strata Critical Medical, Inc.'s (NASDAQ:SRTA) 30% Price Boost Is Out Of Tune With Revenues
Jan 06
Earnings Release: Here's Why Analysts Cut Their Blade Air Mobility, Inc. (NASDAQ:BLDE) Price Target To US$7.20
May 15Blade Air Mobility, Inc. (NASDAQ:BLDE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
May 13
eVTOL And Urban Air Mobility Will Open New Routes
Transition to electric vertical aircraft (eVTOL) promises long-term growth by enabling new routes and attracting a wider customer base.Blade Air Mobility: Organ Transport Growth Now, eVTOL Growth Later
Feb 26Revenues Not Telling The Story For Blade Air Mobility, Inc. (NASDAQ:BLDE) After Shares Rise 27%
Nov 30Blade: Transition To Profitability Should Provide Support Going Forward
Nov 18Analysts Have Made A Financial Statement On Blade Air Mobility, Inc.'s (NASDAQ:BLDE) Third-Quarter Report
Nov 15Blade Air Mobility, Inc.'s (NASDAQ:BLDE) Business Is Trailing The Industry But Its Shares Aren't
Sep 16Blade: Margins Remain An Issue
Aug 15Here's Why We're Not At All Concerned With Blade Air Mobility's (NASDAQ:BLDE) Cash Burn Situation
Jun 19Blade Air Mobility: No Signs Of Competition Yet
May 16Analysts Are Updating Their Blade Air Mobility, Inc. (NASDAQ:BLDE) Estimates After Its First-Quarter Results
May 10Blade Air Mobility, Inc.'s (NASDAQ:BLDE) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Mar 20Blade Air Mobility, Inc. (NASDAQ:BLDE) Annual Results: Here's What Analysts Are Forecasting For This Year
Mar 15We're Not Very Worried About Blade Air Mobility's (NASDAQ:BLDE) Cash Burn Rate
Mar 07Blade Air Mobility, Inc.'s (NASDAQ:BLDE) Share Price Matching Investor Opinion
Jan 24Blade Air Mobility: Takeoff Towards Profitability
Jan 21Shareholder Returns
| SRTA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -2.7% | 6.2% | 3.4% |
| 1Y | 50.2% | -25.4% | 29.7% |
Return vs Industry: SRTA exceeded the US Healthcare industry which returned -25.4% over the past year.
Return vs Market: SRTA exceeded the US Market which returned 29.7% over the past year.
Price Volatility
| SRTA volatility | |
|---|---|
| SRTA Average Weekly Movement | 7.5% |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: SRTA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SRTA's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 327 | Melissa Tomkiel | www.stratacritical.com |
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services.
Strata Critical Medical, Inc. Fundamentals Summary
| SRTA fundamental statistics | |
|---|---|
| Market cap | US$352.31m |
| Earnings (TTM) | -US$20.07m |
| Revenue (TTM) | US$197.14m |
Is SRTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SRTA income statement (TTM) | |
|---|---|
| Revenue | US$197.14m |
| Cost of Revenue | US$156.02m |
| Gross Profit | US$41.13m |
| Other Expenses | US$61.19m |
| Earnings | -US$20.07m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 20.86% |
| Net Profit Margin | -10.18% |
| Debt/Equity Ratio | 0% |
How did SRTA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/10 21:41 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Strata Critical Medical, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Zhi | B. Riley Securities, Inc. |
| Itay Michaeli | Citigroup Inc |
| William Bonello | Craig-Hallum Capital Group LLC |